Pulmonary hypertension in chronic lung disease and hypoxia
SD Nathan, JA Barbera, SP Gaine… - European …, 2019 - Eur Respiratory Soc
Pulmonary hypertension (PH) frequently complicates the course of patients with various
forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated …
forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated …
[HTML][HTML] Idiopathic pulmonary fibrosis: pathogenesis and management
G Sgalla, B Iovene, M Calvello, M Ori, F Varone… - Respiratory …, 2018 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease
characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma …
characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma …
A global view of pulmonary hypertension
Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …
rapidly growing importance in elderly people, particularly in countries with ageing …
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
G Raghu, VC Amatto, J Behr… - European Respiratory …, 2015 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is associated with a fatal prognosis and manifests in
patients over 60 years old who may have comorbidities. The prevalence and impact of …
patients over 60 years old who may have comorbidities. The prevalence and impact of …
Pulmonary hypertension in chronic lung diseases
W Seeger, Y Adir, JA Barberà, H Champion… - Journal of the American …, 2013 - jacc.org
Chronic obstructive lung disease (COPD) and diffuse parenchymal lung diseases (DPLD),
including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high …
including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high …
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
Background Idiopathic interstitial pneumonias are often complicated by pulmonary
hypertension, increasing morbidity and mortality. There are no approved treatments for …
hypertension, increasing morbidity and mortality. There are no approved treatments for …
[HTML][HTML] Physiology of the lung in idiopathic pulmonary fibrosis
L Plantier, A Cazes, AT Dinh-Xuan… - European …, 2018 - Eur Respiratory Soc
The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple
alterations in lung function. These alterations derive from a complex disease process …
alterations in lung function. These alterations derive from a complex disease process …
[HTML][HTML] Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with an estimated
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …
Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017)
K Fukuda, H Date, S Doi, Y Fukumoto… - Circulation …, 2019 - jstage.jst.go.jp
Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …
In the last 2 decades, however, the diagnosis and treatment methods for this disease …
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
V Cottin, J Le Pavec, G Prévot, H Mal… - European respiratory …, 2010 - Eur Respiratory Soc
This study aims to describe the haemodynamic and survival characteristics of patients with
pulmonary hypertension in the recently individualised syndrome of combined pulmonary …
pulmonary hypertension in the recently individualised syndrome of combined pulmonary …